Elisheva Pokroy‐Shapira

Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study

Elisheva Pokroy‐Shapira, Ilana Gelernter, Yair Molad · Clinical Rheumatology · 2014 · 47 citations

Glomerular Disease, Glomerulonephritis, Long-period Follow-up +12

Epstein–Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti‐<scp>DNA</scp>

Ittai Fattal, Noam Shental, Yair Molad et al. · Immunology · 2013 · 45 citations · Full text

Healthy Subjects, Scleroderma Patients, Immunology +19

Serum Soluble Triggering Receptor on Myeloid Cells-1 (sTREM-1) is Elevated in Systemic Lupus Erythematosus but does not Distinguish Between Lupus Alone and Concurrent Infection

Yair Molad, Elisheva Pokroy‐Shapira, Tania Kaptzan et al. · Inflammation · 2013 · 34 citations

Inflammation, Autoimmune Disease, Systemic Lupus Erythematosus +10

CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding

Yair Molad, Elisheva Pokroy‐Shapira, Vered Carmon · Innate Immunity · 2013 · 23 citations

Immunology, Immune Regulation, Innate Immunity +16

Soluble triggering receptor expressed on myeloid cells‐1 is a biomarker of anti‐<scp>CCP</scp>‐positive, early rheumatoid arthritis

Yair Molad, Shachaf Ofer‐Shiber, Elisheva Pokroy‐Shapira et al. · European Journal of Clinical Investigation · 2015 · 19 citations